Bill
H 1167
Overview: H 1167, An Act to enact pharmacy benefit manager duties, was reported favorably by committee and referred to the committee on Health Care Financing. It was introduced on
Overview: H 1167, An Act to enact pharmacy benefit manager duties, was reported favorably by committee and referred to the committee on Health Care Financing. It was introduced on February 27, 2025.
Purpose and Intent: The bill aims to establish new duties and requirements for pharmacy benefit managers (PBMs) in order to increase transparency and accountability in the prescription drug supply chain.
Key Provisions:
- Requires PBMs to obtain a license from the state and meet certain financial and operational standards
- Mandates PBMs to disclose information about their business practices, including fees, reimbursement rates, and rebate agreements
- Prohibits PBMs from engaging in certain practices, such as clawbacks, spread pricing, and requiring patients to use mail-order pharmacies
- Gives the state insurance commissioner oversight and enforcement authority over PBM activities
Affected Parties and Impacts: The bill would impact PBMs operating in the state, as well as pharmacies, health plans, and ultimately consumers who rely on prescription drugs. The increased transparency and restrictions on PBM practices aim to lower drug costs and improve patient access.
Procedural and Timeline Considerations: The bill has been reported favorably by committee and now moves to the committee on Health Care Financing for further consideration. If passed, the new PBM regulations would likely take effect within 6-12 months to allow for implementation.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
